modafinil and mln8054

modafinil has been researched along with mln8054 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Burris, H; Cohen, RB; Danaee, H; Dees, EC; Ecsedy, J; Eton, O; Fingert, H; Galvin, K; Infante, JR; Jones, S; Lee, Y; Liu, H; Manfredi, M; O'Neil, BH; Stringer, B; von Mehren, M	1

Trials

1 trial(s) available for modafinil and mln8054

Article	Year
Phase 1 study of MLN8054, a selective inhibitor of Aurora A kinase in patients with advanced solid tumors. Cancer chemotherapy and pharmacology, 2011, Volume: 67, Issue:4 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Aurora Kinases; Benzazepines; Benzhydryl Compounds; Central Nervous System Stimulants; Disorders of Excessive Somnolence; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Half-Life; Humans; Male; Maximum Tolerated Dose; Methylphenidate; Middle Aged; Modafinil; Neoplasms; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Young Adult	2011

Article

Year

Phase 1 study of MLN8054, a selective inhibitor of Aurora A kinase in patients with advanced solid tumors.

Cancer chemotherapy and pharmacology, 2011, Volume: 67, Issue:4

Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Aurora Kinases; Benzazepines; Benzhydryl Compounds; Central Nervous System Stimulants; Disorders of Excessive Somnolence; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Half-Life; Humans; Male; Maximum Tolerated Dose; Methylphenidate; Middle Aged; Modafinil; Neoplasms; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Young Adult

2011